Septic shock is associated with excessive sympathetic stimulation that can result in cardiac dysfunction and tachycardia. Despite beta-blockers historically being considered a relative contraindication in sepsis, recent literature has suggested that ultrashort acting beta-blockers may be an effective treatment option in controlling sepsis related tachycardia as well as overcoming the negative effects of excessive sympathetic stimulation. Please join Dr. Smith for a virtual presentation as he discusses the specific mechanisms in which sepsis and excessive sympathetic stimulation can result in cardiac dysfunction and the potential role ultrashort beta-blockers can have to overcome these negative effects. This session will focus on analyzing recent literature examining beta-blocker therapy in sepsis to identify patient characteristics that may see benefits or harms in receiving beta-blocker therapy.
To learn more about this activity, including speaker information and learning objectives, expand the module below (click the +). Pharmacists can earn 0.75 contact hour of knowledge-based CE credit at the completion of this activity.
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process » Participants are responsible for insuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
Requirements for CE Credit
To claim credit for this session, participants must complete the following steps:
- Visit this site. Make sure you are logged in and registered before proceeding.
- Complete an evaluation by clicking the green evaluation button
- Enter the evaluation code that was given to you at the end of the session you attended.
- Answer all questions honestly - we appreciate your feedback! All responses are stored anonymously.
- Click submit. As soon as you submit, a report containing the NABP ePID and DOB stored in your profile will be automatically sent to CPE Monitor.
- Please allow up to 48 hours for processing. Your credit should appear in your NABP profile online.
If you experience difficulty, please contact our office so that we may assist you. We are happy to help!
Participants are responsible for ensuring accuracy of credit reporting and receipt of credit. It is recommended that participants log on and review the information under "my account" prior to submitting the evaluation. NABP ePID and date of birth must be accurate for credit reporting to occur. Evaluations cannot be reopened after 14 days.
This 45 minute presentation will examine the specific mechanisms in which sepsis and excessive sympathetic stimulation can result in cardiac dysfunction and discuss the potential role ultrashort beta-blockers can have to overcome these negative effects. In addition, the session will focus on analyzing recent literature examining beta-blocker therapy in sepsis to identify patient characteristics that may see benefits or harms in receiving beta-blocker therapy.
- Describe the mechanisms in which sepsis can induce cardiac dysfunction
- Summarize recent literature evaluating beta-blocker therapy in patients with sepsis
- Identify patient specific characteristics that may see the most benefit or harm from starting beta-blocker therapy in sepsis
Jesse Smith, Pharm.D.
Release Date: Jan 11, 2022
Credit Expiration Date: Jan 11, 2022